You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Science this week: genomic investigation of maize's adaption to temperate climates, and more.
In Nucleic Acids Research this week: meta-gene strategy for finding disease biomarkers, web-based tool for finding small RNAs, and more.
They demonstrated the applicability of the Simoa platform for nucleic acid detection, and miRNA detection in particular, as Quanterix prepares to launch a new system.
In Nucleic Acids Research this week: improved method for determining RNA structure, approach for detecting microRNAs digitally, and more.
Using array-based miRNA profiles for individuals treated for prostate cancer, researchers identified 37 miRNA with differential expression in cases with recurrence.
In PLOS this week: root-knot nematode sequencing study, somatic mutations linked to uveal melanoma, and more.
The French firm said that the funds will go toward international development and the marketing of the company's autoimmunity, allergy, and theranostic products.
In PLOS this week: RNA-directed DNA methylation in Arabidopsis, TLR5 variants linked to melioidosis survival, and more.
The New York State Department of Health had previously provided conditional approval of the microRNA classifier for diagnosing indeterminate thyroid cancer cases.
Researchers have developed a spit-based miRNA test to gauge concussion duration in children, NPR reports.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.